Dry Eye: Clinical Trials

56 trials for Dry Eye, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

56 completed. 56 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 456Completed 56

Follow Dry Eye: new trials by email Literature Review of Dry Eye trials Research Report on Dry Eye

Trials (filtered) newest first · largest first

All 56 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Concomitant Perfluorohexyloctane Use With Contact Lens Wear
Perfluorohexyloctane ophthalmic solution - Dry Eye
Phase 4CompletedBausch & Lomb Incorporated1042025-07-022025-12-18
Topical Insulin for Ocular Surface Interface in Dry Eye Disease
Artificial tear, insulin human - Dry Eye, Insulin Sensitivity
Phase 4CompletedKhyber Teaching Hospital1282025-04-142026-08-14
Corneal Changes in Estrogen-Dependent Breast Cancer After Hormonal Treatment
Hormonal treatment - Braest Cancer, Dry Eye
Phase 4CompletedSohag University402024-06-012025-04-11
Treating Lid Wiper Epitheliopathy
Preservative Free eye drop - Dry Eye, Visual Acuity
Phase 4CompletedSouthern College of Optometry522024-05-272025-02-25
A Study to Evaluate the Effect of Miebo™ on Preoperative Biometry/Keratometry and Postoperative Refractive Accuracy
Miebo - Dry Eye
Phase 4CompletedBausch & Lomb Incorporated972024-04-302026-07-06
A Study to Evaluate Early Treatment Outcomes With Miebo™ in Subjects With Dry Eye Disease
Miebo - Dry Eye
Phase 4CompletedBausch & Lomb Incorporated992024-02-282025-10-21
Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical Study
HPMC+GlicoPro eyedrops, Hydroxypropyl-methylcellulose - Dry Eye
Phase 4CompletedUniversity of Milan442024-02-032024-12-10
Subjective and Objective Performance of Systane Complete Multi-Dose PF Versus Walgreen's Lubricant Balance
Systane Complete Multi-Dose PF, Walgreen's Lubricant Balance - Dry Eye
Phase 4CompletedScripps Poway Eyecare and Optometry702024-01-182025-04-08
The COAT Trial: Cequa's Onset of Action Trial
Cyclosporine ophthalmic solution - Dry Eye
Phase 4CompletedResearch Insight LLC522023-10-122024-07-01
Evaluation of Miebo (Perfluorohexyloctane) Eyedrops in Habitual Contact Lens Wearers
Miebo - Dry Eye, Dry Eye, Evaporative
Phase 4CompletedGordon Schanzlin New Vision492023-09-212024-04-09
Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya
Nasal Guide - Dry Eye, Keratoconjunctivitis Sicca
Phase 4CompletedOyster Point Pharma, Inc.302023-06-142025-05-06
Nasal Spray Study in Sjogren's Dry Eye Disease
Varenicline Nasal Spray - Sjogren's Syndrome, Dry Eye
Phase 4CompletedUniversity of Pennsylvania392023-05-012024-11-05
Artificial Tears, Tear Lipids and Tear Film Dynamics
Systane Complete PF, Refresh Relieva PF, Refresh Optive Mega-3 PF - Dry Eye
Phase 4CompletedUniversity of California, Berkeley812023-01-302025-03-14
Clinical Trial To Determine The Effectiveness And Safety Of Topical Insulin In Dry Eye
Insulin, Cyclosporins, Artificial tears - Dry Eye, Insulin
Phase 4CompletedBarbara Burgos Blasco1162022-10-192026-03-05
Lifitegrast 5% for the Treatment of Dry Eye In Habitual Soft Contact Lens Wearers
Lifitegrast 5% Ophthalmic Solution, Lifitegrast Ophthalmic Solution Vehicle - Dry Eye
Phase 4CompletedState University of New York College of Optometry322022-09-222025-01-14
Study to Compare the Efficacy of the Ophthalmic Solution Humylub Ofteno® PF With Hyabak® and Lagricel Ofteno® PF as Treatment for Dry Eye.
Sodium hyaluronate 0.1%/chondroitin sulfate 0.18%, Sodium hyaluronate 0.15%, Sodium hyaluronate 0.4% - Dry Eye
Phase 4CompletedLaboratorios Sophia S.A de C.V.1822021-12-092026-02-20
OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers
OC-01 (varenicline 0.6mg/ml) Nasal Spray, Placebo (vehicle) nasal spray - Dry Eye
Phase 4CompletedCenter for Ophthalmic and Vision Research, LLC752021-12-032022-11-03
The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease
artificial tear eyedrops, 0.05% cyclosporine eyedrops - Dry Eye
Phase 4CompletedPeking University Third Hospital602021-12-022025-02-13
Digital Device Users Who Are Treated With Systane Hydration PF
Systane Hydration PF - Dry Eye
Phase 4CompletedUniversity of Alabama at Birmingham302021-08-182022-10-10
The DEPOT Study (Dry Eye Prescription Options for Therapy)
Dexamethasone - Dry Eye
Phase 4CompletedResearch Insight LLC502021-08-102022-01-03

Showing 20 of 56. Sign in to see all of them.

Narrower conditions

Dry Eye Syndromes (56)  ·  Insulin Resistance (2)  ·  Sjogren's Syndrome (2)  ·  Breast Neoplasms (1)  ·  Cataract (1)  ·  Diabetes Mellitus (1)  ·  Keratitis (1)  ·  Keratoconjunctivitis Sicca (1)

Broader conditions

Eye Diseases (56)  ·  Lacrimal Apparatus Diseases (56)  ·  Glucose Metabolism Disorders (3)  ·  Metabolic Diseases (3)  ·  Nutritional and Metabolic Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Arthritis (2)  ·  Arthritis, Rheumatoid (2)  ·  Autoimmune Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Corneal Diseases (2)  ·  Hyperinsulinism (2)  ·  Immune System Diseases (2)  ·  Joint Diseases (2)  ·  Mouth Diseases (2)

Interventions

Cyclosporins (7)  ·  Ophthalmic Solutions (4)  ·  lifitegrast (4)  ·  Cyclosporine (3)  ·  Hyaluronic Acid (3)  ·  Lubricant Eye Drops (3)  ·  perfluorohexyl-octan (3)  ·  Calcium Dobesilate (2)  ·  Insulin (2)  ·  Standard of Care (2)  ·  Carboxymethylcellulose Sodium (1)  ·  Dexamethasone (1)  ·  Hypromellose Derivatives (1)  ·  Loteprednol Etabonate (1)  ·  MCC protocol (1)

Sponsors

Innovative Medical (9)  ·  Alcon Research (5)  ·  Bausch & Lomb Incorporated (3)  ·  Research Insight LLC (3)  ·  University of Alabama at Birmingham (3)  ·  Center for Ophthalmic and Vision Research, LLC (2)  ·  Allergan (1)  ·  Aston University (1)  ·  Barbara Burgos Blasco (1)  ·  Bp Consulting, Inc (1)  ·  Durrie Vision (1)  ·  Gordon Schanzlin New Vision (1)  ·  Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA (1)  ·  Khyber Teaching Hospital (1)  ·  Laboratorios Sophia S.A de C.V. (1)

Countries

United States (33)  ·  Austria (2)  ·  Spain (2)  ·  Canada (1)  ·  China (1)  ·  Egypt (1)  ·  India (1)  ·  Italy (1)  ·  Mexico (1)  ·  Pakistan (1)  ·  Singapore (1)  ·  South Korea (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

John Hovanesian, MD (3)  ·  Andrew Hopkinson, PhD (1)  ·  Barbara Burgos Blasco, MD, PhD (1)  ·  Barry Schechter, MD (1)  ·  Daniel S. Durrie, MD (1)  ·  Danielle Iacono, OD (1)  ·  David Hardten, MD (1)  ·  Edoardo Villani, MD (1)  ·  Eric Donnenfeld, MD (1)  ·  Gail L Torkildsen, M.D. (1)  ·  Hong Qi (1)  ·  Jay Mashouf, OD (1)  ·  Jay S Pepose, MD, PhD (1)  ·  Jerry R Paugh (1)

Results publications

PMID 22475641, PMID 27055211, PMID 27388660, PMID 28375789, PMID 28933582, PMID 30802601, PMID 31741283, PMID 38446281, PMID 39233999, PMID 39985746, PMID 40024993, PMID 40138387, PMID 40166690, PMID 40276144, PMID 41588216, PMID 42415246